{
    "address": "Scheelevagen 19",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W2R933137",
    "description": "BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. The company is headquartered in Lund, Skane and currently employs 91 full-time employees. The company went IPO on 2017-06-21. The company develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.",
    "employeeTotal": "91.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2017-06-21",
    "isin": "SE0009858152",
    "logo": "https://finnhub.io/api/logo?symbol=BONEX.ST",
    "marketCapitalization": 5342.889,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Biological Product (except Diagnostic) Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Bonesupport Holding AB",
    "phone": "46462865370.0",
    "sedol": "BF3NMS2",
    "shareOutstanding": 65.064222,
    "state": "SKANE",
    "ticker": "BONEX.ST",
    "weburl": "https://www.bonesupport.com"
}